Association between reduction in LDL‐C levels and reduction in CRP levels among clinical trials comparing statin monotherapy with ezetimibe/statin combination. The following studies were included in the figure: VYVA: Ballantyne, Am Heart J, 2005; VYMET: Robinson, Am J Cardiol, 2009; EXPLORER: Ballantyne, Am J Cardiol, 2007; ENHANCE: Kastelein, NEJM, 2008; SANDS: Fleg, J Am Coll Cardiol, 2008; A: Sager, Atherosclerosis, 2005; B: Goldberg, Mayo Clin Proc, 2004; C: Bays, Clin Ther, 2004; D: Ballantyne, Circulation, 2003; E: Gagne, Am J Cardiol, 2002.